To use wild resources properly: a lesson from two species of human coronaviruses
Abstract
The global pandemic of COVID-19, a disease caused by a severe acute respiratory syndrome-related coronavirus (SARSr-CoV), is responsible for over a hundred million confirmed cases and more than two hundred deaths worldwide. Accumulating evidence indicates correlations between the abuse of wild resources and the outbreaks. To reduce the risks of getting infected with human coronaviruses (HCoVs), brief introductions to HCoVs were made, the hosts of them are listed, the probable transmission routes of the SARSr-CoVs and MERS-CoVs are analyzed, and the recommendation that we use wild resources properly was put forward.
References
[2] Weiss S R, Navasmartin S. Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus[J]. Microbiology & Molecular Biology Reviews Mmbr, 2005; 69(4):635.
[3] Tyrrell D., Bynoe M.L. Cultivation of a novel type of common cold virus in organ culture[J]. Br Med J. 1965;1(5448):1467-70.
[4] Mcintosh K, Becker W B, Chanock R M. Growth in suckling-mouse brain of “IBV-like†viruses from patients with upper respiratory tract disease[J]. Proceedings of the National Academy of Sciences, 1967; 58(6):2268-2273.
[5] Zumla Alimuddin, Chan Jasper, Azhar Esam, Hui, David, Yuen Kwok-Yung. Coronavirus-drug discovery and therapeutic options[J]. Nature reviews Drug discovery, 2016; 15.
[6] Reilley B, Herp M V, Sermand D et al.. SARS and Carlo Urbani[J]. New England Journal of Medicine, 2003; 348(20):1951-1952.
[7] Peiris Joseph S et al.. Coronavirus as a possible cause of severe acute respiratory syndrome[J]. Lancet, 2003; 361. 1319-25.
[8] van der Hoek Lia et al.. Identification of a new coronavirus[J]. Nature medicine, 2004; 10. 368-73.
[9] Woo Patrick et al.. Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1, from Patients with Pneumonia[J]. Journal of virology, 2005; 79. 884-95.
[10] Zaki A M, Van Boheemen S, Bestebroer T M et al.. Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia[J]. New England Journal of Medicine, 2012; 367(19):1814-1820.
[11] Zhou Peng et al.. A pneumonia outbreak associated with a new coronavirus of probable bat origin[J]. Nature, 2020.
[12] Epidemiology Group of New Coronavirus Pneumonia Emergency Response Mechanism, Chinese Center for Disease Control and Prevention. Analysis of epidemiological characteristics of new coronavirus pneumonia [J]. Chinese Journal of Epidemiology, 2020.
[13] Ben H, Lei-Ping Z, Xing-Lou Y, et al.. Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus[J]. PLOS Pathogens, 2017; 13(11):e1006698.
[14] Guan Y et al.. Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China[J]. Science, 2003; 302(5643):276-278.
[15] Li S Z. Poultry Department Volume 48 [M]. Compendium of Materia Medica.
[16] Wang D et al.. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China[J]. JAMA, 2020.
[17] Huang C , Wang Y , Li X , et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. The Lancet, 2020, 395(10223).
[18] David Cyranoski. Mystery deepens over animal source of coronavirus[J]. Nature, 2020.
[19] Zhou Y, Zhang J, Slade E et al.. Dietary Shifts in Relation to Fruit Availability among Masked Palm Civets (Paguma
larvata) in Central China[J]. Journal of Mammalogy, 2008; 89(2) :4 35-447.
[20] Liu Zhixin et al.. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential
intermediate hosts of SARS-CoV-2[J]. Journal of Medical Virology, 2020.
[21] Lewis, David B. Avian Flu to Human Influenza[J]. Annual Review of Medicine, 2006; 57(1):139-154.
[22] Jones M K, Oliver J D. Vibrio vulnificus: Disease and Pathogenesis[J]. Infection and Immunity, 2009; 77(5):1723-1733.
Copyright (c) 2021 Yimin Zhang
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear
Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.
